Structure |
Chemical Name |
CAS |
MF |
![Entinostat](/CAS/GIF/209783-80-2.gif) |
Entinostat |
209783-80-2 |
C21H20N4O3 |
![Vorinostat](/CAS/GIF/149647-78-9.gif) |
Vorinostat |
149647-78-9 |
C14H20N2O3 |
![Tacedinaline](/CAS/GIF/112522-64-2.gif) |
Tacedinaline |
112522-64-2 |
C15H15N3O2 |
![Sodium 4-phenylbutyrate](/CAS/GIF/1716-12-7.gif) |
Sodium 4-phenylbutyrate |
1716-12-7 |
C10H13NaO2 |
![Panobinostat](/CAS/GIF/404950-80-7.gif) |
Panobinostat |
404950-80-7 |
C21H23N3O2 |
![N-(2-Aminophenyl)-4-([[4-(pyridin-3-yl)pyrimidin-2-yl]amino]methyl)benzamide](/CAS/GIF/726169-73-9.gif) |
N-(2-Aminophenyl)-4-([[4-(pyridin-3-yl)pyrimidin-2-yl]amino]methyl)benzamide |
726169-73-9 |
C23H20N6O |
![Belinostat (PXD101)](/CAS/GIF/414864-00-9.gif) |
Belinostat (PXD101) |
414864-00-9 |
C15H14N2O4S |
![(S)-tert-butyl 2-(4-(4-chlorophenyl)-2,3,9-triMethyl-6H-thieno[3,2-f][1,2,4]triazolo[4,3-a][1,4]diazepin-6-yl)acetate](/CAS/GIF/1268524-70-4.gif) |
(S)-tert-butyl 2-(4-(4-chlorophenyl)-2,3,9-triMethyl-6H-thieno[3,2-f][1,2,4]triazolo[4,3-a][1,4]diazepin-6-yl)acetate |
1268524-70-4 |
C23H25ClN4O2S |
![6-CHLORO-2,3,4,9-TETRAHYDRO-1H-CARBAZOLE-1-CARBOXAMIDE](/CAS/GIF/49843-98-3.gif) |
6-CHLORO-2,3,4,9-TETRAHYDRO-1H-CARBAZOLE-1-CARBOXAMIDE |
49843-98-3 |
C13H13ClN2O |
![SIRTINOL](/CAS/GIF/410536-97-9.gif) |
SIRTINOL |
410536-97-9 |
C26H22N2O2 |
![SRT1720](/CAS/20180808/GIF/1001645-58-4.gif) |
SRT1720 |
1001645-58-4 |
C25H24ClN7OS |
![Lomeguatrib](/CAS/GIF/192441-08-0.gif) |
Lomeguatrib |
192441-08-0 |
C10H8BrN5OS |
![ZEBULARINE](/CAS/GIF/3690-10-6.gif) |
ZEBULARINE |
3690-10-6 |
C9H12N2O5 |
![RVX-208](/CAS/GIF/1044870-39-4.gif) |
RVX-208 |
1044870-39-4 |
C20H22N2O5 |
![I-BET151 (GSK1210151A)](/CAS/GIF/1300031-49-5.gif) |
I-BET151 (GSK1210151A) |
1300031-49-5 |
C23H21N5O3 |
![(2R,3R,4S,5R)-2-(6-aMino-9H-purin-9-yl)-5-((((1r,3S)-3-(2-(5-(tert-butyl)-1H-benzo[d]iMidazol-2-yl)ethyl)cyclobutyl)(isopropyl)aMino)Methyl)tetrahydrofuran-3,4-diol](/CAS/20150408/GIF/1380288-87-8.gif) |
(2R,3R,4S,5R)-2-(6-aMino-9H-purin-9-yl)-5-((((1r,3S)-3-(2-(5-(tert-butyl)-1H-benzo[d]iMidazol-2-yl)ethyl)cyclobutyl)(isopropyl)aMino)Methyl)tetrahydrofuran-3,4-diol |
1380288-87-8 |
C30H42N8O3 |
![S)-1-(sec-butyl)-N-((4,6-diMethyl-2-oxo-1,2-dihydropyridin-3-yl)Methyl)-3-Methyl-6-(6-(piperazin-1-yl)pyridin-3-yl)-1H-indole-4-carboxaMide](/CAS/GIF/1346574-57-9.gif) |
S)-1-(sec-butyl)-N-((4,6-diMethyl-2-oxo-1,2-dihydropyridin-3-yl)Methyl)-3-Methyl-6-(6-(piperazin-1-yl)pyridin-3-yl)-1H-indole-4-carboxaMide |
1346574-57-9 |
C31H38N6O2 |
![MC1568](/CAS/GIF/852475-26-4.gif) |
MC1568 |
852475-26-4 |
C17H15FN2O3 |
![6-pentadecylsalicylic acid](/CAS/GIF/16611-84-0.gif) |
6-pentadecylsalicylic acid |
16611-84-0 |
C22H36O3 |
![1-Cyclopentyl-N-((4,6-diMethyl-2-oxo-1,2-dihydropyridin-3-yl)Methyl)-6-(4-(MorpholinoMethyl)phenyl)-1H-indazole-4-carboxaMide](/CAS/GIF/1396772-26-1.gif) |
1-Cyclopentyl-N-((4,6-diMethyl-2-oxo-1,2-dihydropyridin-3-yl)Methyl)-6-(4-(MorpholinoMethyl)phenyl)-1H-indazole-4-carboxaMide |
1396772-26-1 |
C32H37N5O3 |
![UNC 1999](/CAS/20150408/GIF/1431612-23-5.gif) |
UNC 1999 |
1431612-23-5 |
C33H43N7O2 |
![UNC 0631](/CAS/20150408/GIF/1320288-19-4.gif) |
UNC 0631 |
1320288-19-4 |
C37H61N7O2 |
![5-Carboxy-8-hydroxyquinoline](/CAS/GIF/5852-78-8.gif) |
5-Carboxy-8-hydroxyquinoline |
5852-78-8 |
C10H7NO3 |
![M344](/CAS/GIF/251456-60-7.gif) |
M344 |
251456-60-7 |
C16H25N3O3 |
![RG108](/CAS/GIF/48208-26-0.gif) |
RG108 |
48208-26-0 |
C19H14N2O4 |
![CUDC-101](/CAS/GIF/1012054-59-9.gif) |
CUDC-101 |
1012054-59-9 |
C24H26N4O4 |
![CRA-02478](/CAS/GIF/783355-60-2.gif) |
CRA-02478 |
783355-60-2 |
C21H23N3O5 |
![MS436](/CAS/20150408/GIF/1395084-25-9.gif) |
MS436 |
1395084-25-9 |
C18H17N5O3S |
![2-Propenamide, N-hydroxy-3-[4-[[(2-hydroxyethyl)[2-(1H-indol-3-yl)ethyl]amino]methyl]phenyl]-, (2E)-](/CAS/GIF/404951-53-7.gif) |
2-Propenamide, N-hydroxy-3-[4-[[(2-hydroxyethyl)[2-(1H-indol-3-yl)ethyl]amino]methyl]phenyl]-, (2E)- |
404951-53-7 |
C22H25N3O3 |
![PFI-1](/CAS/GIF/1403764-72-6.gif) |
PFI-1 |
1403764-72-6 |
C16H17N3O4S |
![SP2509](/CAS/GIF/1423715-09-6.gif) |
SP2509 |
1423715-09-6 |
C19H20ClN3O5S |
![(1S,4Z,7S,10S,11E,20R)-4-ethylidene-7,20-dipropan-2-yl-9-oxa-15,16-dit hia-3,6,18,21-tetrazabicyclo[8.7.6]tricos-11-ene-2,5,8,19,22-pentone](/CAS/GIF/128517-07-7.gif) |
(1S,4Z,7S,10S,11E,20R)-4-ethylidene-7,20-dipropan-2-yl-9-oxa-15,16-dit hia-3,6,18,21-tetrazabicyclo[8.7.6]tricos-11-ene-2,5,8,19,22-pentone |
128517-07-7 |
C24H36N4O6S2 |
![Pracinostat](/CAS/GIF/929016-96-6.gif) |
Pracinostat |
929016-96-6 |
C20H30N4O2 |
![4SC-201](/CAS/20150408/GIF/864814-88-0.gif) |
4SC-201 |
864814-88-0 |
C16H19N3O4S |
![JNJ-26481585](/CAS/GIF/875320-29-9.gif) |
JNJ-26481585 |
875320-29-9 |
C21H26N6O2 |
![GSK 525762A](/CAS/20150408/GIF/1260907-17-2.gif) |
GSK 525762A |
1260907-17-2 |
C22H22ClN5O2 |
![PI3K/HDAC Inhibitor](/CAS/GIF/1339928-25-4.gif) |
PI3K/HDAC Inhibitor |
1339928-25-4 |
C23H24N8O4S |
![SGI-1027](/CAS/20150408/GIF/1020149-73-8.gif) |
SGI-1027 |
1020149-73-8 |
C27H23N7O |
![OTX015](/CAS/20150408/GIF/202590-98-5.gif) |
OTX015 |
202590-98-5 |
C25H22ClN5O2S |
![SPLITOMICIN](/CAS/GIF/5690-03-9.gif) |
SPLITOMICIN |
5690-03-9 |
C13H10O2 |
![PCI 34051](/CAS/GIF/950762-95-5.gif) |
PCI 34051 |
950762-95-5 |
C17H16N2O3 |
![JIB-04](/CAS/20150408/GIF/199596-05-9.gif) |
JIB-04 |
199596-05-9 |
C17H13ClN4 |
![GSK 343](/CAS/20150408/GIF/1346704-33-3.gif) |
GSK 343 |
1346704-33-3 |
C31H39N7O2 |
![SGC-CBP30](/CAS/GIF/1613695-14-9.gif) |
SGC-CBP30 |
1613695-14-9 |
C28H33ClN4O3 |
![BroMosporine](/CAS/20150408/GIF/CB52676961.gif) |
BroMosporine |
1619994-69-2 |
C17H20N6O4S |
![SCRIPTAID](/CAS/GIF/287383-59-9.gif) |
SCRIPTAID |
287383-59-9 |
C18H18N2O4 |
![tasquinimod](/CAS/20150408/GIF/254964-60-8.gif) |
tasquinimod |
254964-60-8 |
C20H17F3N2O4 |
![GSK J4 HCl](/CAS/20150408/GIF/1373423-53-0.gif) |
GSK J4 HCl |
1373423-53-0 |
C24H27N5O2 |
![UNC-1215](/CAS/GIF/1415800-43-9.gif) |
UNC-1215 |
1415800-43-9 |
C32H43N5O2 |
![AR-42](/CAS/GIF/935881-37-1.gif) |
AR-42 |
935881-37-1 |
C18H20N2O3 |
![ACY-1215](/CAS/GIF/1316214-52-4.gif) |
ACY-1215 |
1316214-52-4 |
C24H27N5O3 |
![Tazemetostat (EPZ-6438)](/CAS/20150408/GIF/1403254-99-8.gif) |
Tazemetostat (EPZ-6438) |
1403254-99-8 |
C34H44N4O4 |
![EPZ004777](/CAS/20150408/GIF/1338466-77-5.gif) |
EPZ004777 |
1338466-77-5 |
C28H41N7O4 |
![UNC 669](/CAS/20150408/GIF/1314241-44-5.gif) |
UNC 669 |
1314241-44-5 |
C15H20BrN3O |
![RGFP 109](/CAS/20150408/GIF/1215493-56-3.gif) |
RGFP 109 |
1215493-56-3 |
C20H25N3O2 |
![BRD4770](/CAS/20180713/GIF/1374601-40-7.gif) |
BRD4770 |
1374601-40-7 |
C25H23N3O3 |
![EPZ015666](/CAS/20180906/GIF/1616391-65-1.gif) |
EPZ015666 |
1616391-65-1 |
C20H25N5O3 |
![ITF2357](/CAS/20150408/GIF/732302-99-7.gif) |
ITF2357 |
732302-99-7 |
C24H30ClN3O5 |
![3-Cyclopentene-1,2-diol, 5-(4-aMino-1H-iMidazo[4,5-c]pyridin-1-yl)-3-(hydroxyMethyl)-, (Hydrochloride) (1:1), (1S,2R,5R)-](/CAS/GIF/120964-45-6.gif) |
3-Cyclopentene-1,2-diol, 5-(4-aMino-1H-iMidazo[4,5-c]pyridin-1-yl)-3-(hydroxyMethyl)-, (Hydrochloride) (1:1), (1S,2R,5R)- |
120964-45-6 |
C12H15ClN4O3 |
![OG-L002](/CAS/GIF/1357302-64-7.gif) |
OG-L002 |
1357302-64-7 |
C15H15NO |
![OF-1](/CAS/20180713/GIF/919973-83-4.gif) |
OF-1 |
919973-83-4 |
C17H18BrN3O4S |
![Droxinostat](/CAS/GIF/99873-43-5.gif) |
Droxinostat |
99873-43-5 |
C11H14ClNO3 |
![LMK-235](/CAS/20150408/GIF/1418033-25-6.gif) |
LMK-235 |
1418033-25-6 |
C15H22N2O4 |
![4SC-202 (free base)](/CAS/20180808/GIF/910462-43-0.gif) |
4SC-202 (free base) |
910462-43-0 |
C23H21N5O3S |
![RGFP966](/CAS/20180808/GIF/1396841-57-8.gif) |
RGFP966 |
1396841-57-8 |
C21H19FN4O |
![ReModelin hydrobroMide](/CAS/20180906/GIF/1622921-15-6.gif) |
ReModelin hydrobroMide |
1622921-15-6 |
C15H15BrN4S |
![Tubacin](/CAS/GIF/537049-40-4.gif) |
Tubacin |
537049-40-4 |
C41H43N3O7S |
![SRT2104 (GSK2245840)](/CAS/GIF/1093403-33-8.gif) |
SRT2104 (GSK2245840) |
1093403-33-8 |
C26H24N6O2S2 |
![SGC0946](/CAS/GIF/1561178-17-3.gif) |
SGC0946 |
1561178-17-3 |
C28H40BrN7O4 |
![Tubastatin-A](/CAS/20150408/GIF/1252003-15-8.gif) |
Tubastatin-A |
1252003-15-8 |
C20H21N3O2 |
![MM-102](/CAS/20180808/GIF/1417329-24-8.gif) |
MM-102 |
1417329-24-8 |
C35H49F2N7O4 |
![2-Cyano-3-[5-(2,5-dichlorophenyl)-2-furanyl]-N-5-quinolinyl-2-propenamide](/CAS/GIF/304896-28-4.gif) |
2-Cyano-3-[5-(2,5-dichlorophenyl)-2-furanyl]-N-5-quinolinyl-2-propenamide |
304896-28-4 |
C23H13Cl2N3O2 |
![MI-2 (Menin-MLL Inhibitor)](/CAS/GIF/1271738-62-5.gif) |
MI-2 (Menin-MLL Inhibitor) |
1271738-62-5 |
C18H25N5S2 |
![CAY10603](/CAS/20180808/GIF/1045792-66-2.gif) |
CAY10603 |
1045792-66-2 |
C22H30N4O6 |
![MI-3 (Menin-MLL Inhibitor)](/CAS/20150408/GIF/1271738-59-0.gif) |
MI-3 (Menin-MLL Inhibitor) |
1271738-59-0 |
C18H25N5S2 |
![CPI-203](/CAS/20150408/GIF/1446144-04-2.gif) |
CPI-203 |
1446144-04-2 |
C19H18ClN5OS |
![EI1](/CAS/20150408/GIF/1418308-27-6.gif) |
EI1 |
1418308-27-6 |
C23H26N4O2 |
![Nexturastat A](/CAS/20180713/GIF/1403783-31-2.gif) |
Nexturastat A |
1403783-31-2 |
C19H23N3O3 |
![C 646](/CAS/20150408/GIF/328968-36-1.gif) |
C 646 |
328968-36-1 |
C24H19N3O6 |
![GSK1324726A (I-BET726)](/CAS/20150408/GIF/1300031-52-0.gif) |
GSK1324726A (I-BET726) |
1300031-52-0 |
C25H23ClN2O3 |
![PFI3](/CAS/20181012/GIF/1819363-80-8.gif) |
PFI3 |
1819363-80-8 |
C19H19N3O2 |
![PFI-2](/CAS/20180808/GIF/1627676-59-8.gif) |
PFI-2 |
1627676-59-8 |
C23H25F4N3O3S |
![MG149](/CAS/20180808/GIF/1243583-85-8.gif) |
MG149 |
1243583-85-8 |
C22H28O3 |
![CAY10683 (SantacruzaMate A)](/CAS/20180713/GIF/1477949-42-0.gif) |
CAY10683 (SantacruzaMate A) |
1477949-42-0 |
C15H22N2O3 |
![ML234](/CAS/20180906/GIF/1222800-79-4.gif) |
ML234 |
1222800-79-4 |
C21H23N3O2 |
![TMP269](/CAS/20150408/GIF/1314890-29-3.gif) |
TMP269 |
1314890-29-3 |
C25H21F3N4O3S |
![HPOB](/CAS/20180713/GIF/1429651-50-2.gif) |
HPOB |
1429651-50-2 |
C17H18N2O4 |
![BRD73954](/CAS/20180713/GIF/1440209-96-0.gif) |
BRD73954 |
1440209-96-0 |
C16H16N2O3 |
![BIX 01294](/CAS/20180713/GIF/1392399-03-9.gif) |
BIX 01294 |
1392399-03-9 |
C28H41Cl3N6O2 |
![UNC0379](/CAS/GIF/1620401-82-2.gif) |
UNC0379 |
1620401-82-2 |
C23H35N5O2 |
![GSK-LSD1](/CAS/20210111/GIF/1431368-48-7.gif) |
GSK-LSD1 |
1431368-48-7 |
C14H20N2 |